New Mexico program
When treatment is waiting on insurance approval
New Mexico limits cancer-drug approval hurdles and sets response deadlines for plans covered by its laws.
What it is
New Mexico limits cancer-drug approval hurdles and sets response deadlines for plans covered by its laws.
These rules can help when a plan delays treatment approval. The cancer-drug protection and the older decision-deadline law cover different plan groups. HR and the oncology team can help identify which applies.
Eligibility rules
- The 2024 cancer-drug rules apply to group coverage other than small group, issued or renewed on or after January 1, 2025.
- The older prior-authorization law includes specified public-purchasing arrangements and Medicaid health plans. Its scope differs from the newer large-group cancer-drug protection.
- The cancer-drug protection has exceptions when a biosimilar, interchangeable biologic or generic version exists.
What you get
- Covered plans cannot impose certain cancer-drug approval or try-another-drug hurdles.
- Missing an applicable decision deadline can count as approval.
What this includes
- For an approved cancer drug within the law’s scope, neither step therapy nor prior authorization can be required unless a stated alternative-version exception applies.
- An unanswered prior-authorization request is deemed granted after seven days, or 24 hours for an urgent request, once documentation is complete.
- A qualifying step-therapy exception request has a 72-hour decision deadline, or 24 hours in exigent circumstances. Missing the applicable deadline means the exception is granted. The statute also requires continued coverage of the requested drug while a qualifying exception request is pending.
If you decide to apply
- Ask the oncology team when it sent all supporting records and whether the request is urgent.
- Ask the plan for the date it received the final document and the written decision due date.
Your insurer, with the Office of Superintendent of Insurance as the regulator · 505-827-4601 · Official page ↗
After you apply
- The insurer issues an authorization number or written confirmation that the request is deemed granted. A denial can go through internal appeal and then the applicable outside review.
Good to know
The team and insurer check when the necessary records arrived. Cancer-drug protections have separate plan and medicine exceptions.
Other details
- The oncology team can record the request’s receipt date, supporting documents, urgency and the exact provision that applies. A biosimilar, interchangeable biologic or generic equivalent can change the cancer-drug or step-therapy analysis. Reported plan funding alone does not establish New Mexico jurisdiction, and an incomplete-document issue should be checked against the insurer’s own information-request deadlines.
- The step-therapy law took effect May 15, 2024. Cancer-drug provisions specify policies from January 1, 2025 for group coverage other than small group. The insurer confirms the exact drug definition, alternative-version exception and applicable insurance or public-purchasing provision.
Official sources
“Do these cancer-drug rules or decision deadlines apply to our plan? What are the benefits and drawbacks of requesting a review, and could you help if that would support treatment?”
Why I’m asking: We want the plan’s due date and any treatment approval in writing.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Get the due date in writing and hold the plan to it.
Your social worker
The oncology team sends the clinical documentation the clock depends on.
The care team
The doctor states the medical necessity and, when needed, the urgency.
- Who decides
- Your insurer, under rules the insurance regulator enforces.
- Ask the care team
- “Can you confirm the plan has everything it needs, and note this is an approved cancer drug so step therapy should not apply?”
How to apply
First step: Ask the plan in writing when its decision is due and what it is still waiting for.
- Ask the plan in writing when its decision is due and what it is still waiting for.
- If a cancer drug is being held for step therapy, say the drug is cancer treatment and ask for the exception.
- If the deadline passes, ask the plan in writing to confirm the request is deemed granted.
Official application / program page ↗
Where it starts: Ask the plan in writing for the date it received the last supporting document, and the date its decision is due.
What to gather
The diagnosis letter, the child’s insurance card, and the last two pay stubs cover most applications. The official page lists the rest.
How long: Seven days, or twenty-four hours when the doctor says it is urgent.
What a yes looks like
An authorization number, or written confirmation the request is deemed granted.
What a no looks like, and the next move
A denial. Use the plan’s internal appeal, then the outside review.
Watch out
- The clock starts only when the plan has every document. Ask what is missing and when it arrived.
- The 2024 cancer rules do not reach small group plans; ask HR which kind yours is.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
No step therapy and no prior authorization for an approved cancer drug in the plans the law reaches, and deadlines that count as approval when missed.
- $7 — Days before an unanswered prior authorization is deemed granted
- $24 — Hours before an unanswered urgent prior authorization is deemed granted
- $72 — Hours for a decision on a step therapy exception
Legal protection: An approved cancer drug cannot be made subject to step therapy or prior authorization unless a biosimilar, interchangeable biologic or generic version exists · A prior authorization not decided in time is deemed granted · A step therapy exception not answered in time is granted
What it costs the family: Free: these are rules your plan has to follow.
The eligibility facts, as published
- Plan type
- General authorization law reaches specified private, public-purchasing and Medicaid health plans. The newer cancer-drug law has separate large-group scope and exceptions. The insurer confirms the exact applicable provision.
- Timing
- the clock starts when the plan has all the necessary supporting documentation
The trap: The deadline only starts when the plan has all the supporting documents. Ask the plan in writing what it is still waiting for and on what date it received the last piece.
Where I read this
- Step therapy and cancer prior authorization, enrolled SB 135 (2024) — New Mexico Legislature, read September 10, 2026
- Prior Authorization Act, enrolled SB 188 (2019) — New Mexico Legislature, read September 10, 2026
- 13.10.31 NMAC — Prior Authorization — New Mexico Office of Superintendent of Insurance, read September 10, 2026